IMMX
Income statement / Annual
Last year (2023), Immix Biopharma, Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2023, Immix Biopharma, Inc.'s net income was -$15.43 M.
See Immix Biopharma, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
-$89.52 M
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$5,468.00 |
$2,135.00 |
$2,468.00 |
$2,321.00 |
$1,082.00 |
| Gross Profit |
-$5,468.00 |
-$89.52 M |
-$2,468.00 |
-$2,321.00 |
-$1,082.00 |
| Gross Profit Ratio |
0 |
1 |
0 |
0 |
0 |
| Research and Development
Expenses |
$8.74 M
|
$4.20 M
|
$126,527.00
|
$248,149.00
|
$583,162.00
|
| General & Administrative
Expenses |
$7.41 M
|
$4.02 M
|
$1.23 M
|
$205,703.00
|
$259,337.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$7.41 M
|
$4.02 M
|
$1.23 M
|
$205,703.00
|
$259,337.00
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$512.00 |
$224.00 |
| Operating Expenses |
$16.14 M |
$8.22 M |
$1.35 M |
$453,852.00 |
$842,499.00 |
| Cost And Expenses |
$16.14 M |
$8.22 M |
$1.35 M |
$453,852.00 |
$842,499.00 |
| Interest Income |
$572,006.00 |
$0.50 |
$179.85 |
$101.98 |
$109.98 |
| Interest Expense |
$0.00 |
$497.00 |
$179,853.00 |
$101,976.00 |
$109,984.00 |
| Depreciation &
Amortization |
$5,468.00
|
$2,135.00
|
$2,468.00
|
$2,321.00
|
$1,082.00
|
| EBITDA |
-$16.14 M
|
-$8.22 M
|
-$1.35 M
|
-$451,531.00
|
-$841,197.00
|
| EBITDA Ratio |
0 |
0.09 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0.09
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$572,006.00
|
-$497.00
|
-$23.03 M
|
-$676,464.00
|
-$109,760.00
|
| Income Before Tax |
-$15.57 M |
-$8.22 M |
-$24.38 M |
-$1.13 M |
-$952,259.00 |
| Income Before Tax Ratio
|
0
|
0.09
|
0
|
0
|
0
|
| Income Tax Expense |
$26,415.00 |
$10,268.00 |
$6,013.00 |
$17,547.00 |
$20,552.00 |
| Net Income |
-$15.43 M |
-$8.23 M |
-$24.38 M |
-$1.15 M |
-$972,811.00 |
| Net Income Ratio |
0 |
0.09 |
0 |
0 |
0 |
| EPS |
-0.89 |
-0.62 |
-1.84 |
-0.15 |
-0.29 |
| EPS Diluted |
-0.89 |
-0.62 |
-1.84 |
-0.15 |
-0.29 |
| Weighted Average Shares
Out |
$17.34 M
|
$13.23 M
|
$13.23 M
|
$7.77 M
|
$3.38 M
|
| Weighted Average Shares
Out Diluted |
$17.34 M
|
$13.23 M
|
$13.23 M
|
$7.77 M
|
$3.38 M
|
| Link |
|
|
|
|
|
